Randomized phase 2 trial of the Vincristine-Irinotecan combination with or without Temozolomide, in children and adults with relapsed or refractory rhabdomyosarcoma: an EpSSG/ITCC trial.
Loading...
Embargo End Date
ICR Authors
Authors
Chisholm, J
Document Type
Journal Article
Date
Date Accepted
2021-06-17
Abstract
Citation
Journal of Clinical Oncology
DOI
Source Title
Publisher
American Society of Clinical Oncology
ISSN
0732-183X
eISSN
Collections
Research Team
Sarcoma Clinical Trials in children and young people
Sarcoma Clinical Trials in children and young people
Sarcoma Clinical Trials in children and young people